Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study). - Rodriguez, JM; Delgado, M; Viciana, P; Lopez-Ruz, MA; Leal, M; Alcacer, F; Deig, E; Antela, A; Pedrol, E; Moreno, S (Journal of the International AIDS Society, 2010)